|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neff RL, Farrar WB, Kloos RT and Burman
KD: Anaplastic thyroid cancer. Endocrinol Metab Clin North Am.
37:525–538. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smallridge RC, Marlow LA and Copland JA:
Anaplastic thyroid cancer: Molecular pathogenesis and emerging
therapies. Endocr Relat Cancer. 16:17–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Are C and Shaha AR: Anaplastic thyroid
carcinoma: Biology, pathogenesis, prognostic factors, and treatment
approaches. Ann Surg Oncol. 13:453–464. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Passaro C, Abagnale A, Libertini S, Volpe
M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D and Portella
G: Ionizing radiation enhances dl922-947-mediated cell death of
anaplastic thyroid carcinoma cells. Endocr Relat Cancer.
20:633–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Harach HR, Galíndez M, Campero M and
Ceballos GA: Undifferentiated (anaplastic) thyroid carcinoma and
iodine intake in Salta, Argentina. Endocr Pathol. 24:125–131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Marlow LA, Von Roemeling CA, Cooper SJ,
Zhang Y, Rohl SD, Arora S, Gonzales IM, Azorsa DO, Reddi HV, Tun
HW, et al: Foxo3a drives proliferation in anaplastic thyroid
carcinoma through transcriptional regulation of cyclin A1: A
paradigm shift that impacts current therapeutic strategies. J Cell
Sci. 125:4253–4263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG,
Yoo HJ and Lee SJ: CCAAT/enhancer-binding protein-homologous
protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal
pathway in FRO anaplastic thyroid carcinoma cells. Horm Metab Res.
45:9–14. 2013.PubMed/NCBI
|
|
9
|
Yu XM, Jaskula-Sztul R, Ahmed K, Harrison
AD, Kunnimalaiyaan M and Chen H: Resveratrol induces
differentiation markers expression in anaplastic thyroid carcinoma
via activation of Notch1 signaling and suppresses cell growth. Mol
Cancer Ther. 12:1276–1287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim YC and Cha YY:
Epigallocatechin-3-gallate induces growth inhibition and apoptosis
of human anaplastic thyroid carcinoma cells through suppression of
EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol.
104:776–780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Becker N, Chernock RD, Nussenbaum B and
Lewis JS Jr: Prognostic significance of β-human chorionic
gonadotropin and PAX8 expression in anaplastic thyroid carcinoma.
Thyroid. 24:319–326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim KS, Min J-K, Liang ZL, Lee K, Lee JU,
Bae KH, Lee MH, Lee SE, Ryu MJ, Kim SJ, et al: Aberrant l1 cell
adhesion molecule affects tumor behavior and chemosensitivity in
anaplastic thyroid carcinoma. Clin Cancer Res. 18:3071–3078. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gauchotte G, Philippe C, Lacomme S,
Léotard B, Wissler MP, Allou L, Toussaint B, Klein M, Vignaud JM
and Bressenot A: BRAF, p53 and SOX2 in anaplastic thyroid
carcinoma: Evidence for multistep carcinogenesis. Pathology.
43:447–452. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hébrant A, Dom G, Dewaele M, Andry G,
Trésallet C, Leteurtre E, Dumont JE and Maenhaut C: mRNA expression
in papillary and anaplastic thyroid carcinoma: Molecular anatomy of
a killing switch. PLoS One. 7:e378072012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He W, Qi B, Zhou Q, Lu C, Huang Q, Xian L
and Chen M: Key genes and pathways in thyroid cancer based on gene
set enrichment analysis. Oncol Rep. 30:1391–1397. 2013.PubMed/NCBI
|
|
16
|
Xu Y, Deng Y, Ji Z, Liu H, Liu Y, Peng H,
Wu J and Fan J: Identification of thyroid carcinoma related genes
with mRMR and shortest path approaches. PLoS One. 9:e940222014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smyth GK: Limma: Linear models for
microarray dataBioinformatics and Computational Biology Solutions
using R and Bioconductor. Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: Springer; New Yotk, NY: pp. 397–420. 2005,
View Article : Google Scholar
|
|
20
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for gene ontology
analysis. BMC Proc. 3:(Suppl 4). S102009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
23
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9. 1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:(Database issue). D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niissalo A: Cytoscape and its Plugins.
Department of Computer Science University of Helsinki Finland;
2007
|
|
26
|
Pham L, Christadore L, Schaus S and
Kolaczyk ED: Network-based prediction for sources of
transcriptional dysregulation using latent pathway identification
analysis. Proc Natl Acad Sci USA. 108:13347–13352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jamali M and Ester M: TrustWalker: A
random walk model for combining trust-based and item-based
recommendation. Proceedings of the 15th ACM SIGKDD International
Conference on Knowledge Discovery and Data Mining. ACM. New York,
NY. pp. 397–406. 2009;
|
|
29
|
Kim JH: Boostrap prediction intervals and
bias-corrected forecasting. http://cran.rproject.org/web/packages/BootPR/index.html2009.
|
|
30
|
Ruffilli I, Ferrari SM, Colaci M, Ferri C,
Politti U, Antonelli A and Fallahi P: CXCR3 and CXCL10 in
autoimmune thyroiditis. Clin Ter. 165:e237–e242. 2014.(In Italian).
PubMed/NCBI
|
|
31
|
Baloch ZW, Livolsi VA, Asa SL, Rosai J,
Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK and Frable WJ:
Diagnostic terminology and morphologic criteria for cytologic
diagnosis of thyroid lesions: A synopsis of the national cancer
institute thyroid fine-needle aspiration state of the science
conference. Diagn Cytopathol. 36:425–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fallahi P, Ferrari SM, Corrado A,
Giuggioli D, Ferri C and Antonelli A: Targeting chemochine (C-X-C
motif) receptor 3 in thyroid autoimmunity. Recent Pat Endocr Metab
Immune Drug Discov. 8:95–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Antonelli A, Ferrari SM, Fallahi P, Piaggi
S, Di Domenicantonio A, Galleri D, Santarpia L, Basolo F,
Ferrannini E and Miccoli P: Variable modulation by cytokines and
thiazolidinediones of the prototype Th1 chemokine CXCL10 in
anaplastic thyroid cancer. Cytokine. 59:218–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin Q, Li M, Fang D, Fang J and Su SB: The
essential roles of Toll-like receptor signaling pathways in sterile
inflammatory diseases. Int Immunopharmacol. 11:1422–1432. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mardente S, Mari E, Consorti F, Di Gioia
C, Negri R, Etna M, Zicari A and Antonaci A: HMGB1 induces the
overexpression of miR-222 and miR-221 and increases growth and
motility in papillary thyroid cancer cells. Oncol Rep.
28:2285–2289. 2012.PubMed/NCBI
|
|
36
|
Romagnani P, Rotondi M, Lazzeri E, Lasagni
L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L,
Tonacchera M, et al: Expression of IP-10/CXCL10 and MIG/CXCL9 in
the thyroid and increased levels of IP-10/CXCL10 in the serum of
patients with recent-onset Graves' disease. Am J Pathol.
161:195–206. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yousefi S, Hemmann S, Weber M, Hölzer C,
Hartung K, Blaser K and Simon HU: IL-8 is expressed by human
peripheral blood eosinophils. Evidence for increased secretion in
asthma. J Immunol. 154:5481–5490. 1995.PubMed/NCBI
|
|
38
|
Tanaka K, Towata S, Nakao K, Mizuguchi H,
Hayakawa T, Niwa M, Ishii N and Nagayama Y: Thyroid cancer
immuno-therapy with retroviral and adenoviral vectors expressing
granulocyte macrophage colony stimulating factor and interleukin-12
in a rat model. Clin Endocrinol. 59:734–742. 2003. View Article : Google Scholar
|
|
39
|
Kobawala TP, Patel GH, Gajjar DR, Patel
KN, Thakor PB, Parekh UB, Patel KM, Shukla SN and Shah PM: Clinical
utility of serum interleukin-8 and interferon-alpha in thyroid
diseases. J Thyroid Res. 2011:2701492011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bazhenova Elu, Kulikov AV, Tikhonova MA,
Tsybko AS and Popova NK: Effects of stress on corticosterone level,
expression of c-Fos gene and serotonin turnover in brain in mice
with genetic predisposition to catalepsy. Ross Fiziol Zh Im I M
Sechenova. 98:1070–1078. 2012.(In Russian). PubMed/NCBI
|
|
41
|
Zhang X, Zhang L, Yang H, Huang X, Otu H,
Libermann TA, DeWolf WC, Khosravi-Far R and Olumi AF: c-Fos as a
proapoptotic agent in TRAIL-induced apoptosis in prostate cancer
cells. Cancer Res. 67:9425–9434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Watanabe T, Hiasa Y, Tokumoto Y, Hirooka
M, Abe M, Ikeda Y, Matsuura B, Chung RT and Onji M: Protein kinase
R modulates c-Fos and c-Jun signaling to promote proliferation of
hepatocellular carcinoma with hepatitis C virus infection. PLoS
One. 8:e677502013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Salvatore G, Nappi TC, Salerno P, Jiang Y,
Garbi C, Ugolini C, Miccoli P, Basolo F, Castellone MD, Cirafici
AM, et al: A cell proliferation and chromosomal instability
signature in anaplastic thyroid carcinoma. Cancer Res.
67:10148–10158. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ingeson-Carlsson C and Nilsson M: Dual
contribution of MAPK and PI3K in epidermal growth factor-induced
destabilization of thyroid follicular integrity and invasion of
cells into extracellular matrix. Exp Cell Res. 326:210–218. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Brown JC, Miller CJ, Posthumus M,
Schwellnus MP and Collins M: The COL5A1 gene, ultra-marathon
running performance, and range of motion. Int J Sports Physiol
Perform. 6:485–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kusunoki T, Nishida S, Kimoto-Kinoshita S,
Murata K, Satou T and Tomura T: Type IV collagenase and
immunostaining of type IV collagen in human thyroid tumors. Auris
Nasus Larynx. 27:161–165. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kusunoki T, Nishida S, Kimoto-Kinoshita S,
Murata K, Satou T and Tomura T: Type IV collagen, type IV
collagenase activity and ability of cell proliferation in human
thyroid tumours. Asian J Surg. 25:304–308. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kliese N, Gobrecht P, Pachow D, Andrae N,
Wilisch-Neumann A, Kirches E, Riek-Burchardt M, Angenstein F,
Reifenberger G, Riemenschneider MJ, et al: miRNA-145 is
downregulated in atypical and anaplastic meningiomas and negatively
regulates motility and proliferation of meningioma cells. Oncogene.
32:4712–4720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Christner PJ and Ayitey S: Extracellular
matrix containing mutated fibrillin-1 (Fbn1) down regulates Col1a1,
Col1a2, Col3a1, Col5a1, and Col5a2 mRNA levels in Tsk/+ and Tsk/Tsk
embryonic fibroblasts. Amino Acids. 30:445–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cheon DJ, Tong Y, Sim MS, Dering J, Berel
D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE, et al: A
collagen-remodeling gene signature regulated by TGF-β signaling is
associated with metastasis and poor survival in serous ovarian
cancer. Clin Cancer Res. 20:711–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
